CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Nu Skin Enterprises, Inc. - NUS CFD

12.27
0.41%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.13
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

NU Skin Enterprises Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 12.31
Open* 12.13
1-Year Change* -70.7%
Day's Range* 12.13 - 12.42
52 wk Range 16.15-45.55
Average Volume (10 days) 500.54K
Average Volume (3 months) 12.52M
Market Cap 858.24M
P/E Ratio 14.78
Shares Outstanding 49.41M
Revenue 2.00B
EPS 1.17
Dividend (Yield %) 8.981
Beta 1.17
Next Earnings Date Feb 14, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 27, 2024 12.31 0.02 0.16% 12.29 12.51 12.26
Feb 26, 2024 12.29 -0.11 -0.89% 12.40 12.54 12.14
Feb 23, 2024 12.51 0.31 2.54% 12.20 12.60 12.08
Feb 22, 2024 12.19 -0.24 -1.93% 12.43 12.54 12.15
Feb 21, 2024 12.60 -0.21 -1.64% 12.81 13.00 12.30
Feb 20, 2024 12.95 -0.50 -3.72% 13.45 13.47 12.82
Feb 16, 2024 13.54 -0.22 -1.60% 13.76 14.57 13.45
Feb 15, 2024 13.68 -0.35 -2.49% 14.03 14.51 13.34
Feb 14, 2024 17.33 -0.12 -0.69% 17.45 17.61 17.24
Feb 13, 2024 17.31 -0.67 -3.73% 17.98 18.30 17.21
Feb 12, 2024 18.65 1.19 6.82% 17.46 18.75 17.45
Feb 9, 2024 17.53 -0.20 -1.13% 17.73 17.73 17.29
Feb 8, 2024 17.69 0.39 2.25% 17.30 17.87 17.26
Feb 7, 2024 17.31 -0.45 -2.53% 17.76 17.81 17.30
Feb 6, 2024 17.67 0.11 0.63% 17.56 17.98 17.45
Feb 5, 2024 17.63 -0.32 -1.78% 17.95 17.96 17.52
Feb 2, 2024 18.08 -0.31 -1.69% 18.39 18.48 17.95
Feb 1, 2024 18.81 0.25 1.35% 18.56 18.87 18.32
Jan 31, 2024 18.48 0.05 0.27% 18.43 19.05 18.39
Jan 30, 2024 18.56 0.06 0.32% 18.50 18.77 18.37

Nu Skin Enterprises, Inc. Events

Time (UTC) Country Event
Wednesday, May 1, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 NU Skin Enterprises Inc Earnings Release
Q1 2024 NU Skin Enterprises Inc Earnings Release

Forecast

-

Previous

-
Thursday, June 6, 2024

Time (UTC)

17:00

Country

US

Event

NU Skin Enterprises Inc Annual Shareholders Meeting
NU Skin Enterprises Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 2225.66 2695.67 2581.93 2420.42 2679.01
Revenue 2225.66 2695.67 2581.93 2420.42 2679.01
Cost of Revenue, Total 630.915 675.223 658.028 581.42 634.14
Gross Profit 1594.74 2020.45 1923.91 1839 2044.87
Total Operating Expense 2114.81 2461.68 2324.37 2152.99 2438.15
Selling/General/Admin. Expenses, Total 1412.1 1707.38 1643.04 1541.47 1710.32
Research & Development 23.3 27.2 23.3 30.1 23
Operating Income 110.847 233.992 257.564 267.426 240.86
Interest Income (Expense), Net Non-Operating -13.5 -11 -13.1 -19.2 -21.8
Other, Net -8.377 9.467 11.768 6.946 0.606
Net Income Before Taxes 88.97 232.459 256.232 255.172 219.666
Net Income After Taxes 104.778 147.266 191.355 173.553 121.887
Net Income Before Extra. Items 104.778 147.266 191.355 173.553 121.887
Net Income 104.778 147.266 191.355 173.553 121.887
Income Available to Common Excl. Extra. Items 104.778 147.266 191.355 173.553 121.887
Income Available to Common Incl. Extra. Items 104.778 147.266 191.355 173.553 121.887
Diluted Net Income 104.778 147.266 191.355 173.553 121.887
Diluted Weighted Average Shares 50.525 51.427 52.765 55.927 56.476
Diluted EPS Excluding Extraordinary Items 2.07379 2.86359 3.62655 3.10321 2.15821
Dividends per Share - Common Stock Primary Issue 1.54 1.52 1.5 1.48 1.46
Diluted Normalized EPS 2.69766 3.50256 3.62655 3.10321 2.8527
Total Extraordinary Items
Unusual Expense (Income) 48.494 51.87 0 0 70.686
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 500.257 481.462 522.34 537.805 560.615
Revenue 500.257 481.462 522.34 537.805 560.615
Cost of Revenue, Total 135.542 133.588 147.816 173.5 148.1
Gross Profit 364.715 347.874 374.524 364.305 412.515
Total Operating Expense 457.751 465.398 494.881 558.089 509.088
Selling/General/Admin. Expenses, Total 322.209 322.023 328.695 354.465 360.988
Operating Income 42.506 16.064 27.459 -20.284 51.527
Other, Net -5.393 -1.476 -3.104 -8.68 -8.64
Net Income Before Taxes 37.113 14.588 24.355 -28.964 42.887
Net Income After Taxes 26.892 11.376 57.215 -25.39 34.237
Net Income Before Extra. Items 26.892 11.376 57.215 -25.39 34.237
Net Income 26.892 11.376 57.215 -25.39 34.237
Income Available to Common Excl. Extra. Items 26.892 11.376 57.215 -25.39 34.237
Income Available to Common Incl. Extra. Items 26.892 11.376 57.215 -25.39 34.237
Diluted Net Income 26.892 11.376 57.215 -25.39 34.237
Diluted Weighted Average Shares 50.161 50.058 49.634 50.199 50.96
Diluted EPS Excluding Extraordinary Items 0.53611 0.22726 1.15274 -0.50579 0.67184
Dividends per Share - Common Stock Primary Issue 0.39 0.39 0.385 0.385 0.385
Diluted Normalized EPS 0.53611 0.37972 1.39331 -0.11573 0.67184
Unusual Expense (Income) 0 9.787 18.37 30.124
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 759.868 872.95 903.198 740.166 799.237
Cash and Short Term Investments 279.662 355.972 457.211 345.251 399.727
Cash & Equivalents 264.725 339.593 402.683 335.63 386.911
Short Term Investments 14.937 16.379 54.528 9.621 12.816
Total Receivables, Net 56.693 44.083 63.37 50.378 53.282
Accounts Receivable - Trade, Net 47.36 41.299 63.37 50.378 53.282
Total Inventory 346.183 399.931 314.366 275.891 295.821
Prepaid Expenses 42.41 54.799 53.519 52.281 34.597
Other Current Assets, Total 34.92 18.165 14.732 16.365 15.81
Total Assets 1820.97 1906.48 1957.08 1769.01 1694.45
Property/Plant/Equipment, Total - Net 543.54 574.647 623.285 597.93 464.535
Property/Plant/Equipment, Total - Gross 885.726 940.187 973.6 928.97 787.534
Accumulated Depreciation, Total -342.186 -365.54 -350.315 -331.04 -322.999
Goodwill, Net 206.432 206.432 202.979 196.573 196.573
Intangibles, Net 66.701 76.991 89.532 80.321 89.989
Other Long Term Assets, Total 244.429 175.46 138.082 154.016 144.112
Total Current Liabilities 359.243 529.694 542.856 356.76 439.655
Accounts Payable 53.963 49.993 66.174 38.979 47.617
Accrued Expenses 231.405 307.927 352.689 240.462 263.786
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 25 107.5 30 27.5 69.455
Other Current Liabilities, Total 48.875 64.274 93.993 49.819 58.797
Total Liabilities 923.674 993.708 1062.81 893.717 912.579
Total Long Term Debt 389.606 274.099 313.121 334.461 361.008
Long Term Debt 377.466 268.781 305.393 334.461 361.008
Other Liabilities, Total 174.825 189.915 206.828 202.496 111.916
Total Equity 897.296 912.772 894.271 875.289 781.867
Common Stock 0.091 0.091 0.091 0.091 0.091
Additional Paid-In Capital 613.278 601.703 579.801 557.544 552.564
Retained Earnings (Accumulated Deficit) 1939.5 1911.73 1840.74 1727.77 1635.75
Treasury Stock - Common -1569.06 -1526.86 -1461.59 -1324.83 -1326.6
Other Equity, Total -86.509 -73.896 -64.768 -85.292 -79.934
Total Liabilities & Shareholders’ Equity 1820.97 1906.48 1957.08 1769.01 1694.45
Total Common Shares Outstanding 49.5 49.9 50.9 55.6 55.4
Capital Lease Obligations 12.14 5.318 7.728
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 701.122 792.575 773.562 759.868 777.842
Cash and Short Term Investments 249.987 252.326 246.715 278.509 308.004
Cash & Equivalents 233.314 235.554 229.941 264.725 294.136
Short Term Investments 16.673 16.772 16.774 13.784 13.868
Total Receivables, Net 77.251 67.166 60.008 47.36 47.991
Accounts Receivable - Trade, Net 77.251 67.166 60.008 47.36 47.991
Total Inventory 291.103 372.25 366.537 346.183 327.481
Prepaid Expenses 82.781 100.833 100.302 87.816 94.366
Total Assets 1793.09 1893.78 1824.65 1820.97 1763.17
Property/Plant/Equipment, Total - Net 515.247 525.035 536.669 543.54 538.47
Goodwill, Net 229.469 229.469 206.432 206.432 206.432
Intangibles, Net 108.972 112.619 64.711 66.701 68.743
Other Long Term Assets, Total 238.281 234.078 243.271 244.429 171.685
Total Current Liabilities 434.015 445.039 372.768 359.243 365.538
Accounts Payable 48.583 49.529 49.494 53.963 41.62
Accrued Expenses 245.432 255.51 275.774 280.28 281.418
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 140 140 47.5 25 42.5
Total Liabilities 970.904 998.431 931.675 923.674 921.238
Total Long Term Debt 362.896 367.753 372.609 377.466 382.323
Long Term Debt 362.896 367.753 372.609 377.466 382.323
Other Liabilities, Total 173.993 185.639 186.298 186.965 173.377
Total Equity 822.187 895.345 892.97 897.296 841.934
Common Stock 0.091 0.091 0.091 0.091 0.091
Additional Paid-In Capital 619.193 615.579 611.483 613.278 609.886
Retained Earnings (Accumulated Deficit) 1882.46 1938.9 1931.48 1939.5 1901.31
Treasury Stock - Common -1570.72 -1557.78 -1559.08 -1569.06 -1559.97
Other Equity, Total -108.836 -101.446 -91.005 -86.509 -109.385
Total Liabilities & Shareholders’ Equity 1793.09 1893.78 1824.65 1820.97 1763.17
Total Common Shares Outstanding 49.4 50 49.9 49.5 49.7
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 104.778 147.266 191.355 173.553 121.887
Cash From Operating Activities 108.062 141.582 379.141 177.931 202.738
Cash From Operating Activities 72.506 76.32 73.991 76.65 83.003
Deferred Taxes -51.626 5.821 -11.914 1.965 -14.929
Non-Cash Items 75.079 105.795 73.145 58.198 84.661
Cash Taxes Paid 42.1 96 56.2 97.9 123.2
Cash Interest Paid 14.5 8.6 11.2 17.9 20.9
Changes in Working Capital -92.675 -193.62 52.564 -132.435 -71.884
Cash From Investing Activities -67.079 -88.726 -79.428 -71.412 -108.761
Capital Expenditures -59.056 -68.615 -63.823 -66.067 -70.371
Other Investing Cash Flow Items, Total -8.023 -20.111 -15.605 -5.345 -38.39
Cash From Financing Activities -99.504 -104.702 -245.166 -154.794 -116.714
Financing Cash Flow Items -5.077 0 0 -7.243
Total Cash Dividends Paid -77.015 -76.272 -78.387 -82.189 -80.581
Issuance (Retirement) of Stock, Net -42.993 -66.559 -138.57 -3.15 -58.788
Issuance (Retirement) of Debt, Net 25.581 38.129 -28.209 -69.455 29.898
Foreign Exchange Effects -16.347 -11.244 12.506 -3.006 -16.751
Net Change in Cash -74.868 -63.09 67.053 -51.281 -39.488
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 11.376 104.778 47.563 72.953 38.716
Cash From Operating Activities -22.077 108.062 82.537 54.096 7.541
Cash From Operating Activities 16.983 72.506 53.935 35.764 17.13
Deferred Taxes -0.072 -51.626 2.483 4.369 3.292
Non-Cash Items 10.449 75.079 60.131 33.108 15.595
Changes in Working Capital -60.813 -92.675 -81.575 -92.098 -67.192
Cash From Investing Activities -14.696 -67.079 -53.694 -28.483 -10.133
Capital Expenditures -11.487 -59.056 -45.274 -19.818 -10.279
Other Investing Cash Flow Items, Total -3.209 -8.023 -8.42 -8.665 0.146
Cash From Financing Activities 1.38 -99.504 -48.71 12.399 -33.759
Total Cash Dividends Paid -19.392 -77.015 -57.988 -38.685 -19.293
Issuance (Retirement) of Stock, Net 4.184 -42.993 -34.244 4.588 -6.49
Issuance (Retirement) of Debt, Net 16.588 25.581 48.599 51.573 -7.976
Foreign Exchange Effects 0.609 -16.347 -25.59 -13.682 -1.026
Net Change in Cash -34.784 -74.868 -45.457 24.33 -37.377
Financing Cash Flow Items -5.077 -5.077 -5.077
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 14.8914 7439576 -101442 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 12.3554 6172649 218825 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 6.1076 3051276 -5943718 2023-07-31 LOW
Renaissance Technologies LLC Hedge Fund 4.3768 2186596 -98800 2023-06-30 HIGH
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 4.2219 2109202 14193 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.6108 1304342 -2363825 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 2.104 1051153 45782 2023-06-30 LOW
Charles Schwab Investment Management, Inc. Investment Advisor 1.7425 870548 22627 2023-06-30 LOW
Invesco Capital Management LLC Investment Advisor 1.6991 848878 28552 2023-06-30 LOW
Aristotle Capital Boston, LLC Investment Advisor 1.5684 783544 17402 2023-06-30 LOW
Marshall Wace LLP Investment Advisor/Hedge Fund 1.3146 656746 656746 2023-06-30 HIGH
Mellon Investments Corporation Investment Advisor/Hedge Fund 1.1243 561705 11369 2023-09-30 LOW
Parametric Portfolio Associates LLC Investment Advisor 0.9971 498147 -59590 2023-06-30 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 0.9732 486218 -66512 2023-06-30 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.9318 465537 -15028 2023-06-30 LOW
Citadel Advisors LLC Hedge Fund 0.9316 465401 280015 2023-06-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.6132 306370 -52450 2022-12-31 LOW
Principal Global Investors (Equity) Investment Advisor 0.5674 283464 -23448 2023-06-30 LOW
Victory Capital Management Inc. Investment Advisor/Hedge Fund 0.5543 276928 -5070 2023-06-30 LOW
ProShare Advisors LLC Investment Advisor 0.4774 238528 8278 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Nu Skin Enterprises, Inc. Company profile

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc. is a holding company engaged in operating Nu Skin unit. Nu Skin develops and distributes beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products that include Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White and Tru Face. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. The Company operates through seven segments, which consists of seven geographic Nu Skin segments, including Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau, and Europe, Middle East and Africa, which includes Europe as well as Israel, Russia and South Africa.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Nu Skin Enterprises, Inc. revenues increased 4% to $2.7B. Net income decreased 23% to $147.3M. Revenues reflect Nu Skin segment increase of 4% to $2.52B, Manufacturing segment increase of 15% to $172.1M. Net income was offset by Selling expenses increase of 5% to $1.07B (expense), General and administrative expenses-bal increase of 3% to $616M (expense).

Equity composition

Cl. A Common Stock $.001 Par, 03/11, 500M auth., 90,600,000 issd., less 28,600,000 shs. in Treas. @ $495.5M. Insiders & Strategic owns 10.36%. IPO: 11/96, 4,750,000 Cl. A shs @ $23 by Merrill Lynch & Co.*NOTE:5/98, Name changed from Nu Skin Asia Pacific.

Industry: Personal Products (NEC)

Attn: D. Matthew Dorny
75 West Center St
PROVO
UTAH 84601
US

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

XRP/USD

0.57 Price
-3.470% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

US100

17,861.70 Price
-0.560% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0039%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

60,636.60 Price
+6.750% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Oil - Crude

78.20 Price
-0.190% 1D Chg, %
Long position overnight fee 0.0219%
Short position overnight fee -0.0438%
Overnight fee time 22:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading